Vimarsana
Biggest News Aggregation in the World

Page 42 - Robert Langer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robert Langer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robert Langer Today - Breaking & Trending Today

New Launches Focus On Non-Coding RNAs and Chronic Kidney Disease - Vimarsana News

New Launches Focus On Non-Coding RNAs and Chronic Kidney Disease

Two new biotech companies launched today: NextRNA to focus on non-coding RNA technology, and Pathalys, with a clinic-ready licensed compound and plans to enter Phase III trials.

School of Engineering welcomes new faculty - Vimarsana News

School of Engineering welcomes new faculty

17 new professors join the MIT School of Engineering community, with research areas ranging from robotics and machine learning to health care and agriculture.

Source: mit.edu
Coronavirus Medicine and Gömböc: How Are Hungarian Scientists' Inventions Related? - Vimarsana News

Coronavirus Medicine and Gömböc: How Are Hungarian Scientists' Inventions Related?

The Gömböc will be useful now in connection to the treatment of coronavirus. Both the Gömböc and the Pfizer vaccine were discovered by Hungarian scientists.

Moderna co-founder Robert Langer not surprised by vaccine doubts - Vimarsana News

Moderna co-founder Robert Langer not surprised by vaccine doubts

Robert Langer, one of the scheduled Imagine Solutions Conference speakers on March 7 in Naples, said the science behind the COVID-19 vaccine is revolutionary

Pfizer CEO expects more people will need COVID pills in future, essentially admitting vaccines don't work - Vimarsana News

Pfizer CEO expects more people will need COVID pills in future, essentially admitting vaccines don't work

Pfizer CEO Albert Bourla on Tuesday, February 8, predicted that the company will manufacture 120 million doses of the Wuhan coronavirus (COVID-19) pill Paxlovid in 2022 – 30 million in the first two quarters and 90 million in the last two quarters of the year. The antiviral drug received emergency use authorization from the Food and Drug […]